In the largest study of its kind, researchers from Children's Hospital of Philadelphia (CHOP) used electronic health record (EHR) data from more than 200,000 pediatric patients to describe patterns of pediatric allergies ...
Jul 25, 2023
0
18
"Don't eat me," is how one might translate the signal that the cancer cells in a glioblastoma send to the macrophages (white blood cells specialized in removing dead and dying cellular matter) in the brain. Immunotherapy ...
Jul 19, 2023
0
16
MUSC researchers have identified a novel biomarker that could change the way sepsis is approached and treated. Sepsis, the leading cause of death in intensive care units, is the body's extreme response to an infection and ...
Jul 18, 2023
0
24
Black patients with implantable cardioverter defibrillators (ICDs) have a significantly higher burden of disease than white patients with the same device, according to a new study from University of Rochester Medical Center ...
Jul 17, 2023
0
22
Black people face a higher risk of developing severe liver fibrosis, but a new study suggests personalized care could help mitigate that risk.
Jul 5, 2023
0
0
Patients recovering from a severe spinal-cord injury can develop an immune deficiency that puts them at risk of developing life-threatening infections, according to a new study by researchers at The Ohio State University ...
Jun 30, 2023
0
2
A new study from Keck Medicine of USC has uncovered significant racial disparities in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the United States.
Jun 13, 2023
0
2
More than 296 million people worldwide live with hepatitis B, a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). Most don't know they are infected, so they don't get medical care. Clinical ...
Jun 6, 2023
0
8
Racial bias built into a common medical test for lung function is likely leading to fewer Black patients getting care for breathing problems, a study published Thursday suggests.
Jun 2, 2023
0
23
There's one question that Hollings Cancer Center researcher Jennifer Dahne, Ph.D., co-director of the remote and virtual trials program at the South Carolina Clinical & Translational Research Institute, hears more than any ...
Jun 1, 2023
0
4
